Market
  • Company Info.

    Novelix Pharmaceuticals Ltd.

    Live Quotes



    Registered Address
    Registered Office : 5-8-354/1106, office no. 1106, Ratna Block, Raghav Ratna towers, Chirag Ali Lane,Abids,
    Hyderabad, Telangana - 500095
    Tel: 040-24757370
    Email : [email protected]
    Website : http://www.trimurthidrugs.com

    Key Officials
    NameDesignation
    Ms. Vani MandaChief Financial Officer
    Ms. Nishita KalantriCo. Secretary & Compl. Officer

    Listings
    BSE  

    Corporate News

    Board Meetings
    Date Purpose
    13/11/2024 Quarterly Results & Others
    21/10/2024 To consider issue of Warrants
    02/09/2024 Others

    Share Holding Pattern as on 30/09/2024
    Major Holder No. of Shares Percentage(%)
    Promoters 6,622,733 66.56
    Institutional Investors 0 0.00
    Other Investors 1,325,317 13.32
    General Public 2,001,950 20.12

    Registrar Details
    Venture Capital & Corporate Investments Pvt. Ltd.
    4th & 5th Floors, Plot No.57, Jayabheri Enclave Phase - II, Gachi
    Hyderabad,500032,Telangana
    Tel : 040-23818475 / 23818
    Fax : 27632184

    Today's Market

    Market Performance
    Exchange BSE
    Last Traded Price ( ` ) 23.00
    Last Traded Date 25/11/2024
    Last Traded Time -
    Change (%) -
    Day's Open ( ` ) 23.00
    Previous Close ( ` ) 23.00
    Day's High ( ` ) 23.00
    Day's Low ( ` ) 23.00
    Total Traded Qty 600
    Value ( ` In Lacs) 0.14
    Bid Price ( ` ) 0.00
    Bid Quantity 0
    Offer Price ( ` ) 0
    Offer Quantity 0
    Exchange Code 536565
    Exchange Group XT
  • Novelix Pharmaceuticals Ltd.

    Company Profile



    Market Cap.(`) 22.89 Cr. P/BV 2.49 Book Value (`) 9.25
    52 Week High/Low ( ` ) 23/8 FV/ML 10/1 P/E(X) 143.75
    Book Closure 27/09/2024 EPS (`) 0.16 Div Yield (%) 0.00
    Registered Office
    Registered Office : 5-8-354/1106, office no. 1106, Ratna Block, Raghav Ratna towers, Chirag Ali Lane,Abids,,
    Hyderabad, Telangana - 500095
    Tel: 040-24757370,
    Website :http://www.trimurthidrugs.com
    Email :[email protected]
    Registrar & Share Transfer Agent
    Venture Capital & Corporate Investments Pvt. Ltd.
    4th & 5th Floors, Plot No.57, Jayabheri Enclave Phase - II, Gachi, , , Hyderabad - 500032, Telangana
    Tel : 040-23818475 / 23818,     Fax : 27632184
    Other Details
    Business Group Not Applicable
    BSE Code 536565
    NSE Code --
    Listings BSE
    ISIN No. INE314I01036
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : [email protected]   |  For any DP Grievance mail to : [email protected].   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html